Assessment of Quality of Life in Turkish Women with Hirsutism: A Cross-Sectional Study

    October 2023 in “ Acta Medica Nicomedia ”
    Şükran Sarıgül Güdük, Sadiye Kuş
    Image of study
    TLDR Hirsutism greatly lowers the quality of life for Turkish women.
    This study evaluated the quality of life in 40 Turkish women diagnosed with hirsutism, a condition of excessive hair growth, using the Dermatology Life Quality Index (DLQI) assessment. The mean age of the participants was 21.4±6.98 years. The study found that hirsutism significantly impairs the quality of life among these women, as indicated by the average DLQI score of 8.83± 5.66. This was independent of their modified Ferriman-Gallwey (mFG) scores, a system used to evaluate the degree of hirsutism. The DLQI scores of the hirsutism patients were significantly different from a control group of 18 patients without hirsutism (p<0.01). The study concluded that hirsutism is a significant issue affecting the quality of life of Turkish women, regardless of mFG scores.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 24 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  36 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Similar Research

    5 / 1000+ results